Clal Biotechnology Industries Ltd (CBI) — Cash Flow-to-Debt Ratio
Clal Biotechnology Industries Ltd (CBI) has a Cash Flow-to-Debt Ratio of -0.05x as of June 2025, meaning its operating cash flow of ILA-1.06 Million could theoretically repay 0% of its total liabilities (ILA19.52 Million) in one year. See CBI free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clal Biotechnology Industries Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Clal Biotechnology Industries Ltd across 19 annual periods. Also explore CBI year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Clal Biotechnology Industries Ltd (2006–2024)
Year-by-year debt coverage analysis for Clal Biotechnology Industries Ltd. For market capitalisation and broader financial context, see Clal Biotechnology Industries Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.30x | ILA-6.48 Million | ILA21.52 Million | ▼ -30.7% |
| 2023 | -0.23x | ILA-8.51 Million | ILA36.98 Million | ▲ +85.3% |
| 2022 | -1.56x | ILA-59.04 Million | ILA37.79 Million | ▼ -302.7% |
| 2021 | -0.39x | ILA-41.33 Million | ILA106.55 Million | ▼ -17.0% |
| 2020 | -0.33x | ILA-33.23 Million | ILA100.24 Million | ▼ -246.1% |
| 2019 | 0.23x | ILA27.03 Million | ILA119.12 Million | ▲ +138.7% |
| 2018 | -0.59x | ILA-86.98 Million | ILA148.46 Million | ▼ -45.0% |
| 2017 | -0.40x | ILA-91.41 Million | ILA226.14 Million | ▼ -31.4% |
| 2016 | -0.31x | ILA-112.63 Million | ILA366.21 Million | ▲ +7.9% |
| 2015 | -0.33x | ILA-147.00 Million | ILA440.31 Million | ▼ -23.4% |
| 2014 | -0.27x | ILA-115.95 Million | ILA428.44 Million | ▲ +1.8% |
| 2013 | -0.28x | ILA-148.98 Million | ILA540.45 Million | ▼ -20.2% |
| 2012 | -0.23x | ILA-81.22 Million | ILA354.19 Million | ▲ +68.2% |
| 2011 | -0.72x | ILA-102.45 Million | ILA142.01 Million | ▲ +10.9% |
| 2010 | -0.81x | ILA-111.93 Million | ILA138.20 Million | ▼ -43.0% |
| 2009 | -0.57x | ILA-86.86 Million | ILA153.41 Million | ▼ -63.6% |
| 2008 | -0.35x | ILA-52.41 Million | ILA151.47 Million | ▲ +18.4% |
| 2007 | -0.42x | ILA-47.05 Million | ILA110.98 Million | ▲ +77.5% |
| 2006 | -1.88x | ILA-23.55 Million | ILA12.50 Million | — |